The Japanese health ministry on February 24 approved label expansions for a batch of medicines including a pediatric indication for Pfizer’s sedative agent Precedex (dexmedetomidine)
Areas covered: Although sodium polystyrene sulfonate has been a mainstay of acute management of hyperkalemia for decades, evidence regarding its efficacy is limited, and its chronic use is not routinely recommended for concerns regarding toxicity.
Objective: We aim to evaluate, for the first time, the analgesic efficacy, safety, and tolerability of cebranopadol in patients suffering from moderate to severe acute pain following bunionectomy.
In this article, we present a case of a patient with relapsed Hodgkin lymphoma who responded to salvage chemotherapy incorporating brentuximab vedotin, a novel agent.
With opioid misuse and abuse on the rise and death counts increasing from overdoses, pain management is becoming more difficult.1 One effective class of medication is opioids, especially those that act on the mu-opioid receptor...
The Mundipharma network of independent associated companies announced that it has acquired from CellAct the worldwide development,commercialization and manufacturing rights to CAP7.1.
Discover the complexities of cystinosis, a genetic disorder caused by CTNS gene mutations, leading to toxic cystine crystal accumulation in lysosomes. This review explores the geographic variations in cystinosis, its clinical manifestations, and the need for novel treatments beyond cysteamine therapy.
Pulmonary hypertension is a multifactorial disease with a high morbidity and mortality.
Dexmedetomidine (DEX) is a Alpha-2 specific agonist, is a common ICU sedation medication. In brain tumor resection craniotomy, it is proven to be effective in improving postoperative hypertension and...
Myasthenia gravis (MG), a prototype autoimmune neurological disease, had its therapy centred on corticosteroids, non-steroidal broad-spectrum immunotherapy and cholinesterase inhibitors for several decades.